NYSE · CNMD
Healthcare · Medical - Devices
$44.48
Down-$0.25 (-0.56%)
Updated Oct 7, 2026, 10:29 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · CNMD
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
CNMD closed at $44.48 after 21 trading sessions, down 4.53% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $47.83 | $48.25 | $44.31 | $44.48 | 456.37K |
| Oct 5, 2026 | $46.43 | $47.77 | $46.11 | $47.33 | 343.34K |
| Oct 2, 2026 | $46.88 | $47.06 | $46.1601 | $46.32 | 240.74K |
| Oct 1, 2026 | $46.18 | $46.59 | $45.73 | $45.93 | 222.4K |
| Sep 30, 2026 | $46.66 | $47.18 | $46.17 | $46.23 | 290.08K |
| Sep 29, 2026 | $46.31 | $46.79 | $45.25 | $46.69 | 228.99K |
| Sep 28, 2026 | $44.91 | $46.75 | $44.50 | $46.48 | 374.85K |
| Sep 25, 2026 | $45.30 | $46.51 | $45.095 | $45.38 | 282.6K |
| Sep 24, 2026 | $45.59 | $45.945 | $44.785 | $45.18 | 263.32K |
| Sep 23, 2026 | $45.48 | $46.15 | $44.745 | $45.80 | 491.16K |
| Sep 22, 2026 | $45.37 | $46.545 | $45.22 | $46.17 | 441.78K |
| Sep 21, 2026 | $45.82 | $45.83 | $44.39 | $44.69 | 354.66K |
| Sep 18, 2026 | $45.73 | $46.13 | $45.095 | $45.42 | 780.48K |
| Sep 17, 2026 | $47.31 | $47.31 | $46.07 | $46.13 | 307.1K |
| Sep 16, 2026 | $46.60 | $47.94 | $46.37 | $47.04 | 296.75K |
| Sep 15, 2026 | $46.01 | $47.17 | $45.625 | $46.95 | 458.09K |
| Sep 14, 2026 | $47.32 | $47.32 | $46.17 | $46.38 | 322.59K |
| Sep 11, 2026 | $47.53 | $47.53 | $45.85 | $46.30 | 237.57K |
| Sep 10, 2026 | $46.43 | $47.095 | $45.90 | $46.22 | 240.83K |
| Sep 9, 2026 | $46.61 | $47.20 | $46.08 | $46.93 | 262.29K |
| Sep 8, 2026 | $48.62 | $49.09 | $45.9144 | $46.59 | 331.71K |
The latest Smart Investors Daily articles mentioning CNMD.
Company
Market Activity
Research & News
CNMD research
Company profile and research snapshot.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 30, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 29, 2026 | B of A Securities | Underperform | — |
| May 18, 2026 | B of A Securities | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.
Yahoo · Oct 1, 2026
LARGO, Fla., October 01, 2026--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Yahoo · Sep 24, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.
SeekingAlpha · Sep 19, 2026
In Q2 2026, the Harbor SMID Cap Value ETF returned 22.76%, outperforming its benchmark, the Russell 2500 Value Index, which returned 18.50%. Read more here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CNMD.
